Company Filing History:
Years Active: 2011
Title: Innovations of Sung-II Kim in Pharmaceutical Chemistry
Introduction
Sung-II Kim is a notable inventor based in Yangju-si, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as vanilloid receptor antagonists. His work aims to address various medical conditions through innovative pharmaceutical compositions.
Latest Patents
Sung-II Kim holds a patent for "Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same." This invention relates to novel compounds that act as antagonists for the vanilloid receptor (Vanilloid Receptor 1; VR1; TRPV1). The pharmaceutical composition developed by Kim is designed to prevent or treat a range of diseases, including pain, migraine, arthralgia, neuralgia, neuropathies, nerve injury, skin disorders, urinary bladder hypersensitivity, irritable bowel syndrome, fecal urgency, respiratory disorders, irritation of skin, eye or mucous membrane, stomach-duodenal ulcers, inflammatory diseases, ear diseases, and heart diseases. He has 1 patent to his name.
Career Highlights
Sung-II Kim is associated with Amorepacific Corporation, a leading company in the beauty and health industry. His role at the company allows him to leverage his expertise in pharmaceutical innovations to contribute to the development of effective health solutions.
Collaborations
Throughout his career, Kim has collaborated with esteemed colleagues, including Young-Ger Suh and Hee-Doo Kim. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical field.
Conclusion
Sung-II Kim's contributions to pharmaceutical chemistry, particularly through his innovative patent, highlight his commitment to advancing medical science. His work continues to pave the way for new treatments that can significantly improve patient care.